Approval of Supartz and Supartz Fx Supartz was approved by the U.S. FDA on January 24, 2001 for the treatment of knee osteoarthritis in patients who failed to obtain sufficient relief with conservative treatments, including exercise, physical therapy, pain medications, mobility aids, and hot or cold packs.